RiboX Advances In Vivo CAR-T With RXIM002 FDA Clearance
SHANGHAI, China and CAMBRIDGE, Mass., USA – August 8, 2026 RiboX Therapeutics Ltd. announced that the U.S. Food and...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SHANGHAI, China and CAMBRIDGE, Mass., USA – August 8, 2026 RiboX Therapeutics Ltd. announced that the U.S. Food and...
Garden City, New York, USA, August 8, 2026 Pulse Health has announced the launch of Pulse Media, a new...
NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...
BOSTON, June 12, 2026 Volta Labs, a leader in genomics workflow automation, has announced the launch of Twist Bioscience’s...
CAMBRIDGE, Massachusetts, USA & PALO ALTO, California, USA, June 3, 2026 Alnylam Pharmaceuticals and Inceptive Nucleics have announced a...
Research Triangle Park, North Carolina, March 16, 2026 IQVIA Holdings Inc. announced the launch of IQVIA.ai, a next-generation unified...
PLEASANTON, CA — March 10, 2026 Veeva Systems announced the acquisition of Ostro, a leading AI-driven brand engagement platform...
DUBLIN, Feb. 13, 2026 — A new two-day virtual Life Science Technical Accounting Update Training Conference 2026 has been...
